Skip to content

Treatment of mild to moderate heart and spleen deficiency depression using Jianpi Jieyu Decoction: a multi-center randomized controlled study

Treatment of mild to moderate heart and spleen deficiency depression using Jianpi Jieyu Decoction: an efficacy and functional characteristics study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040922
Enrollment
Unknown
Registered
2020-12-15
Start date
2017-12-05
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Sponsors

Xiyuan Hospital, Chinese Academy of Chinese
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the above-mentioned Western medical diagnosis and TCM syndrome differentiation standards; 2. Age 18-65 years old, no gender limit; 3. The HAMD-17 score is >= 17 points, = 2 points; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Suicidal tendency, suicide item in HAMD >= 2 points; 2. With severe anxiety symptoms, HAMA >= 21 points; 3. Patients with serious or unstable heart, liver, kidney, endocrine, blood and other medical diseases; 4. Depressive episodes secondary to other mental or physical diseases; 5. Depressive episodes of bipolar disorder; 6. Those who have taken paroxetine or other antidepressants within 5 weeks; 7. Those who are unsupervised or unable to take medication as prescribed by a doctor; 8. People with allergies; 9. Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
HAMA;Evaluation table of TCM symptoms;CGI;

Countries

China

Contacts

Public ContactXia Hong

Xiyuan Hospital, Chinese Academy of Chinese

970236538@qq.com+86 13699207252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026